ReviewInternational journal of molecular sciences2025

Prolonged Low-Dose Administration of FDA-Approved Drugs for Non-Cancer Conditions: A Review of Potential Targets in Cancer Cells.

Olivia Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.